Mechanisms Underlying Cardiomyocyte Development: Can We Exploit Them to Regenerate the Heart?
Gabriel Maldonado-VelezAnthony B FirulliPublished in: Current cardiology reports (2021)
Targeting the endogenous gene regulatory networks (GRNs) shown to play roles in the cardiac regeneration of conducive species is seen as a strong approach, as delivery of a single or combination of genes has promise to effectively enhance cell cycle activity and CM proliferation in adult hearts post-myocardial infarction (MI). In situ re-induction of proliferative gene regulatory programs within existing, local, non-damaged cardiomyocytes helps overcome significant technical hurdles, such as successful engraftment of implanted cells or achieving complete cardiomyocyte differentiation from cell-based approaches. Although many obstacles currently exist and need to be overcome to successfully translate these approaches to clinical settings, the current efforts presented here show great promise.
Keyphrases
- cell cycle
- cell proliferation
- induced apoptosis
- left ventricular
- heart failure
- high glucose
- angiotensin ii
- big data
- stem cells
- signaling pathway
- cell cycle arrest
- single cell
- cell therapy
- public health
- genome wide
- endothelial cells
- atrial fibrillation
- cancer therapy
- quality improvement
- pi k akt
- endoplasmic reticulum stress
- machine learning
- gene expression
- bone marrow
- childhood cancer
- genetic diversity
- mesenchymal stem cells